Decheng Capital China Life Sciences USD Fund II L.P. 13D and 13G filings for Apexigen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-08 12:18 pm Purchase |
2022-07-29 | 13G | Apexigen, Inc. APGN |
Decheng Capital China Life Sciences USD Fund II L.P. | 1,894,551 8.800% |
1,894,551 (New Position) |
Filing |